BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32580249)

  • 21. Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
    Koo T; Lim DH; Seol HJ; Dho YS; Kim IH; Chang JH; Lee J; Jung TY; Gwak HS; Cho KH; Hong CK; Lee IJ; Kim E; Kim JH; Hong YK; Jang HS; Kim CY; Kim IA; Kim SH; Kim YI; Kim EY; Kim WC; Hong S
    J Neurooncol; 2018 Nov; 140(2):445-455. PubMed ID: 30097825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of surgery in optic pathway/hypothalamic gliomas in children.
    Goodden J; Pizer B; Pettorini B; Williams D; Blair J; Didi M; Thorp N; Mallucci C
    J Neurosurg Pediatr; 2014 Jan; 13(1):1-12. PubMed ID: 24138145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
    Krishnatry R; Zhukova N; Guerreiro Stucklin AS; Pole JD; Mistry M; Fried I; Ramaswamy V; Bartels U; Huang A; Laperriere N; Dirks P; Nathan PC; Greenberg M; Malkin D; Hawkins C; Bandopadhayay P; Kieran MW; Manley PE; Bouffet E; Tabori U
    Cancer; 2016 Apr; 122(8):1261-9. PubMed ID: 26970559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurosurgical treatment of oligodendroglial tumors in children and adolescents: a single-institution series of 35 consecutive patients.
    Lundar T; Due-Tønnessen BJ; Egge A; Scheie D; Stensvold E; Brandal P
    J Neurosurg Pediatr; 2013 Sep; 12(3):241-6. PubMed ID: 23870041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of primary thalamic low-grade glioma in pediatric patients: results of the multicenter treatment studies HIT-LGG 1996 and SIOP-LGG 2004.
    Boesten T; Gerber NU; Kandels D; Azizi AA; Schmidt R; Warmuth-Metz M; Pietsch T; Kortmann RD; Gnekow A; Grotzer MA
    Neurooncol Pract; 2017 Mar; 4(1):29-39. PubMed ID: 31385995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doubling Recruitment of Pediatric Low-grade Glioma within Two Decades does not change Outcome - Report from the German LGG Studies.
    Gnekow AK; Kandels D; Pietsch T; Bison B; Warmuth-Metz M; Thomale UW; Kortmann RD; Timmermann B; Driever PH; Witt O; Schmidt R; Spix C
    Klin Padiatr; 2021 May; 233(3):107-122. PubMed ID: 33971689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade Glioma.
    Gnekow AK; Kandels D; Tilburg CV; Azizi AA; Opocher E; Stokland T; Driever PH; Schouten-van Meeteren AYN; Thomale UW; Schuhmann MU; Czech T; Goodden JR; Warmuth-Metz M; Bison B; Avula S; Kortmann RD; Timmermann B; Pietsch T; Witt O
    Klin Padiatr; 2019 May; 231(3):107-135. PubMed ID: 31108561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Craniospinal irradiation for treatment of metastatic pediatric low-grade glioma.
    Tsang DS; Murphy ES; Ezell SE; Lucas JT; Tinkle C; Merchant TE
    J Neurooncol; 2017 Sep; 134(2):317-324. PubMed ID: 28623604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.
    Paulino AC; Mazloom A; Terashima K; Su J; Adesina AM; Okcu MF; Teh BS; Chintagumpala M
    Cancer; 2013 Jul; 119(14):2654-9. PubMed ID: 23633429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
    Fangusaro J; Onar-Thomas A; Young Poussaint T; Wu S; Ligon AH; Lindeman N; Banerjee A; Packer RJ; Kilburn LB; Goldman S; Pollack IF; Qaddoumi I; Jakacki RI; Fisher PG; Dhall G; Baxter P; Kreissman SG; Stewart CF; Jones DTW; Pfister SM; Vezina G; Stern JS; Panigrahy A; Patay Z; Tamrazi B; Jones JY; Haque SS; Enterline DS; Cha S; Fisher MJ; Doyle LA; Smith M; Dunkel IJ; Fouladi M
    Lancet Oncol; 2019 Jul; 20(7):1011-1022. PubMed ID: 31151904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.
    McDuff SGR; Dietrich J; Atkins KM; Oh KS; Loeffler JS; Shih HA
    Cancer Med; 2020 Jan; 9(1):3-11. PubMed ID: 31701682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial impact of high-field intraoperative magnetic resonance imaging on the efficacy of pediatric low-grade glioma surgery.
    Roder C; Breitkopf M; Ms ; Bisdas S; Freitas Rda S; Dimostheni A; Ebinger M; Wolff M; Tatagiba M; Schuhmann MU
    Neurosurg Focus; 2016 Mar; 40(3):E13. PubMed ID: 26926053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges in the management of childhood low-grade glioma in a developing country.
    Abdalla K; Abdullah S; Almehdar A; Elimam N; Abrar MB; Jastaniah W
    Childs Nerv Syst; 2018 May; 34(5):861-870. PubMed ID: 29396719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervicomedullary tumors in children.
    McAbee JH; Modica J; Thompson CJ; Broniscer A; Orr B; Choudhri AF; Boop FA; Klimo P
    J Neurosurg Pediatr; 2015 Oct; 16(4):357-66. PubMed ID: 26114990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiotherapy in pediatric pilocytic astrocytomas. A subgroup analysis within the prospective multicenter study HIT-LGG 1996 by the German Society of Pediatric Oncology and Hematology (GPOH).
    Müller K; Gnekow A; Falkenstein F; Scheiderbauer J; Zwiener I; Pietsch T; Warmuth-Metz M; Voges J; Nikkhah G; Flentje M; Combs SE; Vordermark D; Kocher M; Kortmann RD
    Strahlenther Onkol; 2013 Aug; 189(8):647-55. PubMed ID: 23831852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma.
    Indelicato DJ; Rotondo RL; Uezono H; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Bradley JA
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):149-156. PubMed ID: 30684665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
    Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
    J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity.
    Kortmann RD; Timmermann B; Taylor RE; Scarzello G; Plasswilm L; Paulsen F; Jeremic B; Gnekow AK; Dieckmann K; Kay S; Bamberg M
    Strahlenther Onkol; 2003 Sep; 179(9):585-97. PubMed ID: 14628124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.
    Pollack IF; Claassen D; al-Shboul Q; Janosky JE; Deutsch M
    J Neurosurg; 1995 Apr; 82(4):536-47. PubMed ID: 7897512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.